Companies / Chile
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Morning-After Pill Controversy Mounts
December 2006 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Free distribution of the morning-after pill is still not available in many parts of Chile despite recent court victories by Health Ministry (Minsa) against challenges to the controversial treatment. Furthermore, the only company with a registration for the product has stopped making it, presumably because of lack of demand. Currently, women can only get the drug at some government-run clinics, and opponents to the morning-after pill continue to challenge Minsa's policy. BMI is optimistic that the drug will be made widely available but cautions that it may take some